Bacterial Modulation of Fc Effector Functions

Antibody Fc: Linking Adaptive and Innate Immunity

Volumn , Issue , 2013, Pages 317-332

  Collin, Mattias ^a   Kilian, Mogens ^b  

^a LUND UNIVERSITY   (Sweden)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Glycan hydrolysis; Glycosylation; Immune evasion; Immunoglobulin; Immunoglobulin binding; Proteases

Indexed keywords

EID: 84902435162     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-394802-1.00018-2     Document Type: Chapter

References (125)

1. Navarre WW, Schneewind O Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 1999, 63:174-229.
2. Jensen K A normally occurring Staphylococcus antibody in human serum. Acta Path Microbiol Scand 1958, 44:421-428.
3. Forsgren A, Sjöquist J "Protein A" from S. aureus. I. Pseudo-immune reaction with human γ-globulin. J Immunol 1966, 97:822-827.
4. Kim HK, Thammavongsa V, Schneewind O, Missiakas D Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr Opin Microbiol 2012, 15:92-99.
5. Kronvall G A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G. J Immunol 1973, 111:1401-1406.
6. Björck L, Kronvall G Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 1984, 133:969-974.
7. Åkesson P, Cooney J, Kishimoto F, Björck L Protein H-a novel IgG binding bacterial protein. Mol Immunol 1990, 27:523-531.
8. Åkesson P, Schmidt KH, Cooney J, Björck L M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J 1994, 300(Pt. 3):877-886.
9. O'Toole PW, O'Toole P, Stenberg L, Rissler M, Lindahl G Two major classes in the M protein family in group A streptococci. Proc Natl Acad Sci USA 1992, 89:8661-8665.
10. Stenberg L, O'Toole P, Lindahl G Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type. Mol Microbiol 1992, 6:1185-1194.
11. Lindahl G, Åkerström B, Vaerman JP, Stenberg L Characterization of an IgA receptor from group B streptococci: specificity for serum IgA. Eur J Immunol 1990, 20:2241-2247.
12. Lindahl G, Åkerström B Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli. Mol Microbiol 1989, 3:239-247.
13. Stenberg L, O'Toole PW, Mestecky J, Lindahl G Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J Biol Chem 1994, 269:13458-13464.
14. Johnsson E, Areschoug T, Mestecky J, Lindahl G An IgA-binding peptide derived from a streptococcal surface protein. J Biol Chem 1999, 274:14521-14524.
15. Sandin C, Linse S, Areschoug T, Woof JM, Reinholdt J, Lindahl G Isolation and detection of human IgA using a streptococcal IgA-binding peptide. J Immunol 2002, 169:1357-1364.
16. Jerlström PG, Talay SR, Valentin-Weigand P, Timmis KN, Chhatwal GS Identification of an immunoglobulin A binding motif located in the beta-antigen of the C protein complex of group B streptococci. Infect Immun 1996, 64:2787-2793.
17. Hedén L-O, Frithz E, Lindahl G Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur J Immunol 1991, 21:1481-1490.
18. Myhre EB, Erntell M A non-immune interaction between the light chain of human immunoglobulin and a surface component of a Peptococcus magnus strain. Mol Immunol 1985, 22:879-885.
19. Kastern W, Sjöbring U, Björck L Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain. J Biol Chem 1992, 267:12820-12825.
20. Nilson BH, Solomon A, Björck L, Åkerström B Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. J Biol Chem 1992, 267:2234-2239.
21. Björck L Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. J Immunol 1988, 140:1194-1197.
22. de Château M, Nilson B, Erntell M, et al. On the interaction between protein L and immunoglobulins of various mammalian species. Scand J Immunol 1993, 37:399-405.
23. Nilson B, Lögdeberg L, Kastern W, Björck L, Åkerström B Purification of antibodies using protein L-binding framework structures in the light chain variable domain. J Immunol Meth 1993, 164(1):33-40.
24. Kihlberg BM, Sjöbring U, Kastern W, Björck L Protein LG: a hybrid molecule with unique immunoglobulin binding properties. J Biol Chem 1992, 267:25583-25588.
25. Svensson HG, Hoogenboom HR, Sjöbring U Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fab-binding properties. Eur J Biochem 1998, 258:890-896.
26. Forsgren A, Grubb AO Many bacterial species bind human IgD. J Immunol 1979, 122:1468-1472.
27. Akkoyunlu M, Ruan M, Forsgren A Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains. Infect Immun 1991, 59:1231-1238.
28. Forsgren A, Brant M, Möllenkvist A, Muyombwe A, Janson H, Woin N, et al. Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis. J Immunol 2001, 167:2112-2120.
29. Samuelsson M, Forsgren A, Riesbeck K Purification of IgD from human serum-a novel application of recombinant M. catarrhalis IgD-binding protein (MID). J Immunol Meth 2006, 317:31-37.
30. Zhang L, Jacobsson K, Vasi J, Lindberg M, Frykberg L A second IgG-binding protein in Staphylococcus aureus. Microbiology 1998, 144(Pt. 4):985-991.
31. Smith EJ, Visai L, Kerrigan SW, Speziale P, Foster TJ The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect Immun 2011, 79:3801-3809.
32. Haupt K, Reuter M, van den Elsen J, Burman J, Hälbich S, Richter J, et al. The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog 2008, 4:e1000250.
33. Fagan PK, Reinscheid D, Gottschalk B, Chhatwal GS Identification and characterization of a novel secreted immunoglobulin binding protein from group A streptococcus. Infect Immun 2001, 69:4851-4857.
34. Okamoto S, Terao Y, Hasuike K, Hamada S, Kawabata S A novel streptococcal leucine zipper protein (Lzp) binds to human immunoglobulins. Biochem Biophys Res Commun 2008, 377:1128-1134.
35. Berge A, Björck L Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 1995, 270:9862-9867.
36. Raeder R, Woischnik M, Podbielski A, Boyle MD A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol 1998, 149:539-548.
37. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 1996, 104:321-338.
38. Takenouchi-Ohkubo N, Mortensen LM, Drasbek KR, Kilian M, Poulsen K Horizontal transfer of the immunoglobulin A1 protease gene (IgA) from Streptococcus to Gemella haemolysans. Microbiology 2006, 152:2171-2180.
39. Bek-Thomsen M, Poulsen K, Kilian M Occurrence and evolution of the paralogous zinc metalloproteases IgA1 protease, ZmpB, ZmpC, and ZmpD in Streptococcus pneumoniae and related commensal species. MBio 2012, 3(5):e00303-e00312.
40. Fujiyama Y, Iwaki M, Hodohara K, Hosoda S, Kobayashi K The site of cleavage in human alpha chains of IgA1 and IgA2:A2m(1) allotype paraproteins by the clostridial IGA protease. Mol Immunol 1986, 23:147-150.
41. Kosowska K, Reinholdt J, Rasmussen LK, et al. The Clostridium ramosum IgA proteinase represents a novel type of metalloendopeptidase. J Biol Chem 2002, 277:11987-11994.
42. Pohlner J, Halter R, Beyreuther K, Meyer TF Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature 1987, 325:458-462.
43. Poulsen K, Brandt J, Hjorth JP, Thøgersen HC, Kilian M Cloning and sequencing of the immunoglobulin A1 protease gene (IgA) of Haemophilus influenzae serotype b. Infect Immun 1989, 57:3097-3105.
44. Poulsen K, Reinholdt J, Kilian M Characterization of the Streptococcus pneumoniae immunoglobulin A1 protease gene (iga) and its translation product. Infect Immun 1996, 64:3957-3966.
45. Bender MH, Weiser JN The atypical amino-terminal LPNTG-containing domain of the pneumococcal human IgA1-specific protease is required for proper enzyme localization and function. Mol Microbiol 2006, 61:526-543.
46. Polissi A, Pontiggia A, Feger G, et al. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 1998, 66:5620-5629.
47. Hava DL, Camilli A Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 2002, 45:1389-1406.
48. Kilian M, Poulsen K, Blomqvist T, Håvarstein LS, Bek-Thomsen M, Tettelin H, et al. Evolution of Streptococcus pneumoniae and its close commensal relatives. PLoS ONE 2008, 3:e2683.
49. Chiavolini D, Memmi G, Maggi T, Iannelli F, Pozzi G, Oggioni MR The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice. BMC Microbiol 2003, 3:14.
50. Reinholdt J, Kilian M Comparative analysis of immunoglobulin A1 protease activity among bacteria representing different genera, species, and strains. Infect Immun 1997, 65:4452-4459.
51. Vitovski S, Read RC, Sayers JR Invasive isolates of Neisseria meningitidis possess enhanced immunoglobulin A1 protease activity compared to colonizing strains. FASEB J 1999, 13:331-337.
52. Vitovski S, Dunkin KT, Howard AJ, Sayers JR Nontypeable Haemophilus influenzae in carriage and disease: a difference in IgA1 protease activity levels. JAMA 2002, 287:1699-1705.
53. Plaut AG The IgA1 proteases of pathogenic bacteria. Annu Rev Microbiol 1983, 37:603-622.
54. - cells. J Infect Dis 1992, 166:43-52.
55. Sørensen CH, Kilian M Bacterium-induced cleavage of IgA in nasopharyngeal secretions from atopic children. Acta Pathol Microbiol Immunol Scand C 1984, 92:85-87.
56. Ahl T, Reinholdt J Detection of immunoglobulin A1 protease-induced Fab alpha fragments on dental plaque bacteria. Infect Immun 1991, 59:563-569.
57. Hedges SR, Mayo MS, Kallman L, Mestecky J, Hook EW, Russell MW Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae. Infect Immun 1998, 66:5826-5832.
58. Kirkeby L, Rasmussen TT, Reinholdt J, Kilian M Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria. Clin Diagn Lab Immunol 2000, 7:31-39.
59. Cooper MD, McGee ZA, Mulks MH, Koomey JM, Hindman TL Attachment to and invasion of human fallopian tube mucosa by an IgA1 protease-deficient mutant of Neisseria gonorrhoeae and its wild-type parent. J Infect Dis 1984, 150:737-744.
60. Farley MM, Stephens DS, Mulks MH, Cooper MD, Bricker JV, Mirra SS, et al. Pathogenesis of IgA1 protease-producing and -nonproducing Haemophilus influenzae in human nasopharyngeal organ cultures. J Infect Dis 1986, 154:752-759.
61. Johannsen DB, Johnston DM, Koymen HO, Cohen MS, Cannon JGA Neisseria gonorrhoeae immunoglobulin A1 protease mutant is infectious in the human challenge model of urethral infection. Infect Immun 1999, 67:3009-3013.
62. Kilian M, Russell MW Microbial evasion of IgA functions. Handbook of mucosal immunology 1999, 241-251. Academic Press, San Diego, CA. J.F. Mestecky, E.M. Lamm, W. Strober, J. Bienenstock, R.J. McGhee (Eds.).
63. Mansa B, Kilian M Retained antigen-binding activity of Fab alpha fragments of human monoclonal immunoglobulin A1 (IgA1) cleaved by IgA1 protease. Infect Immun 1986, 52:171-174.
64. Jarvis GA, Griffiss JM Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J Immunol 1991, 147:1962-1967.
65. Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA 2003, 100:4215-4220.
66. Kilian M, Reinholdt J A hypothetical model for the development of invasive infection due to IgA1 protease-producing bacteria. Adv Exp Med Biol 1987, 216B:1261-1269.
67. Nizet V Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol 2007, 120:13-22.
68. Pawel-Rammingen von U, Johansson BP, Björck L IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 2002, 21:1607-1615.
69. Pawel-Rammingen von U, Johansson B, Tapper H, Björck L Streptococcus pyogenes and phagocytic killing. Nat Med 2002, 8:1044-1045.
70. Söderberg JJ, Pawel-Rammingen von U The streptococcal protease IdeS modulates bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime polymorphonuclear leucocytes. Mol Immunol 2008, 45:3347-3353.
71. Pawel-Rammingen von U Streptococcal IdeS and its impact on immune response and inflammation. J Innate Immun 2012, 4:132-140.
72. Pawel-Rammingen von U, Björck L IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr Opin Microbiol 2003, 6:50-55.
73. Johansson BP, Shannon O, Björck L IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS ONE 2008, 3:e1692.
74. Nandakumar KS, Johansson BP, Björck L, Holmdahl R Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum 2007, 56:3253-3260.
75. Nandakumar K, Holmdahl R Therapeutic cleavage of IgG: new avenues for treating inflammation. Trends Immunol 2008, 29:173-178.
76. Kilian M Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens. Infect Immun 1981, 34:757-765.
77. Döring G, Obernesser HJ, Botzenhart K Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA [author's transl.]. Zentralbl Bakteriol A 1981, 249:89-98.
78. Heck LW, Alarcon PG, Kulhavy RM, Morihara K, Russell MW, Mestecky JF Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J Immunol 1990, 144:2253-2257.
79. Loomes LM, Senior BW, Kerr MA A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect Immun 1990, 58:1979-1985.
80. Loomes L, Kerr M, Senior B The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. J Med Microbiol 1993, 39:225-232.
81. Carroll RK, Musser JM From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production. Mol Microbiol 2011, 81:588-601.
82. Nelson DC, Garbe J, Collin M Cysteine proteinase SpeB from Streptococcus pyogenes-a potent modifier of immunologically important host and bacterial proteins. Biol Chem 2011, 392:1077-1088.
83. Collin M, Olsén A Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 2001, 69:7187-7189.
84. Collin M, Svensson MD, Sjöholm AG, Jensenius JC, Sjöbring U, Olsén A EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 2002, 70:6646-6651.
85. Rudd P, Elliott T, Cresswell P, Wilson I, Dwek R Glycosylation and the immune system. Science 2001, 291:2370-2376.
86. Scanlan CN, Burton DR, Dwek RA Making autoantibodies safe. Proc Natl Acad Sci USA 2008, 105:4081-4082.
87. Baenziger J, Kornfeld S Structure of the carbohydrate units of IgA1 immunoglobulin. I. Composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide units. J Biol Chem 1974, 249:7260-7269.
88. Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, Lellouch AC, et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J Biol Chem 1998, 273:2260-2272.
89. Reinholdt J, Tomana M, Mortensen SB, Kilian M Molecular aspects of immunoglobulin A1 degradation by oral streptococci. Infect Immun 1990, 58:1186-1194.
90. Collin M, Olsén A EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 2001, 20:3046-3055.
91. Sjögren J, Okumura CYM, Collin M, Nizet V, Hollands A Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence. BMC Microbiol 2011, 11:120.
92. Burton D, Dwek R Immunology. Sugar determines antibody activity. Science 2006, 313:627-628.
93. Lim P, Zouali M Pathogenic autoantibodies: emerging insights into tissue injury. Immunol Lett 2006, 103:17-26.
94. Colvin R, Smith R Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005, 5:807-817.
95. Lood C, Allhorn M, Lood R, Gullstrand B, Olin AI, Rönnblom L, et al. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment?. Arthritis Rheum 2012, 64:2698-2706.
96. Benkhoucha M, Molnarfi N, Santiago-Raber M-L, Weber MS, Merkler D, Collin M, et al. IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis. J Neuroinflammation 2012, 9:209.
97. Yang R, Otten MA, Hellmark T, Collin M, Björck L, Zhao M-H, et al. Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant 2010, 25:2479-2486.
98. van Timmeren MM, van der Veen BS, Stegeman CA, Petersen AH, Hellmark T, Collin M, et al. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol 2010, 21:1103-1114.
99. Allhorn M, Briceño JG, Baudino L, Lood C, Olsson ML, Izui S, et al. The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis. Blood 2010, 115:5080-5088.
100. Allhorn M, Collin M Sugar-free antibodies-the bacterial solution to autoimmunity?. Ann N Y Acad Sci 2009, 1173:664-669.
101. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci USA 2008, 105:15005-15009.
102. Collin M, Shannon O, Björck L IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci USA 2008, 105:4265-4270.
103. Tradtrantip L, Ratelade J, Zhang H, Verkman AS Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 IgG into therapeutic antibody. Ann Neurol 2012, [Epub ahead of print].
104. Collin M, Fischetti VA A novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B. J Biol Chem 2004, 279:22558-22570.
105. Garbe J, Sjögren J, Cosgrave E, Struwe WB, Bober M, Olin AI, et al. EndoE from Enterococcus faecalis cleaves the glycans of the biofilm inhibiting protein lactoferrin and is regulated via carbon catabolite repression. PLoS ONE [Under revision].
106. Collin M, Olsén A Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 2003, 71:2983-2992.
107. Flock M, Frykberg L, Sköld M, Guss B, Flock J-I Antiphagocytic function of an IgG glycosyl hydrolase from Streptococcus equi subsp. equi and its use as a vaccine component. Infect Immun 2012, 80:2914-2919.
108. Kilian M, Mestecky J, Kulhavy R, Tomana M, Butler WT IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies. J Immunol 1980, 124:2596-2600.
109. Frandsen EV Carbohydrate depletion of immunoglobulin A1 by oral species of gram-positive rods. Oral Microbiol Immunol 1994, 9:352-358.
110. Garbe J, Collin M Bacterial hydrolysis of host glycoproteins-powerful protein modification and efficient nutrient acquisition. J Innate Immun 2012, 4:121-131.
111. Genovese A, Borgia G, Björck L, Petraroli A, de Paulis A, Piazza M, et al. Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human FcγRI+cells through interaction with the κ light chains of IgE. J Immunol 2003, 170:1854-1861.
112. Berge A, Kihlberg B-M, Sjöholm A, Björck L Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J Biol Chem 1997, 272:20774-20781.
113. Fischetti VA Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989, 2:285-314.
114. Thern A, Stenberg L, Dahlbäck B, Lindahl G Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol 1995, 154:375-386.
115. Russell-Jones GJ, Gotschlich EC, Blake MS A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen. J Exp Med 1984, 160:1467-1475.
116. Gjörloff Wingren A, Hadzic R, Forsgren A, Riesbeck K The novel IgD binding protein from Moraxella catarrhalis induces human B lymphocyte activation and Ig secretion in the presence of Th2 cytokines. J Immunol 2002, 168:5582-5588.
117. Ruan MR, Akkoyunlu M, Grubb A, Forsgren A Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J Immunol 1990, 145:3379-3384.
118. Plaut AG, Gilbert JV, Artenstein MS, Capra JD Neisseria gonorrhoeae and Neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science 1975, 190:1103-1105.
119. Mulks MH, Plaut AG IgA protease production as a characteristic distinguishing pathogenic from harmless neisseriaceae. N Engl J Med 1978, 299:973-976.
120. Kilian M, Mestecky J, Schrohenloher RE Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect Immun 1979, 26:143-149.
121. Muramatsu H, Tachikui H, Ushida H, Song X-J, Qiu Y, Yamamoto S, et al. Molecular cloning and expression of endo-β-N-acetylglucosaminidase D, which acts on the core structure of complex type asparagine-linked oligosaccharides. J Biochem 2001, 129:923-928.
122. Muramatsu T, Koide N, Maeyama K Further studies on endo-β-N-acetylglucosaminidase D1. J Biochem 1978, 83:363-370.
123. King SJ, Hippe KR, Weiser JN Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol Microbiol 2006, 59:961-974.
124. Burnaugh AM, Frantz LJ, King SJ Growth of Streptococcus pneumoniae on human glycoconjugates is dependent upon the sequential activity of bacterial exoglycosidases. J Bacteriol 2008, 190:221-230.
125. Renzi F, Manfredi P, Mally M, Moes S, Jenö P, Cornelis GR The N-glycan glycoprotein deglycosylation complex (Gpd) from Capnocytophaga canimorsus deglycosylates human IgG. PLoS Pathog 2011, 7:e1002118.